永安藥業(002365.SZ)擬3600萬元收購中極氫能源60%股權
格隆匯 2 月 1日丨永安藥業(002365.SZ)公佈,2021年2月1日,公司召開第五屆董事會第二十次會議審議通過《關於收購潛江中極氫能源發展有限公司60%股權的議案》,同意公司以自有資金收購中極氫能源60%的股權,轉讓總價款為人民幣3600萬元。此次交易完成後,公司將成為中極氫能源的新進股東。同日,公司與富陽化工、中極氫能源正式簽署《股權轉讓協議》。
氫能屬於清潔能源,發展氫能是國家優化能源消費結構的戰略選擇,投資氫能順應國家產業發展方向,以及符合地方政府發展循環經濟和建立產業集羣的政策。收購中極氫能源是公司踐行轉型發展戰略的舉措,有利於培育新的發展方向和利潤增長點,並且中極氫能源採用煤制氫,成本相對較低,經濟可行性更高。此次投資完成後,公司將進一步整合雙方資源,優勢互補,增強協同效應,儘快產生效益,但也可能存在市場狀況變化、人員整合困難、經營能力不足等情況,導致不達預期的風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.